In Brief This Week: Eppendorf; SDIX; EMD Millipore; Addgene, MJFF | GenomeWeb

NEW YORK (GenomeWeb News) – Eppendorf this week opened its new UK headquarters in the Arlington Business Park in Stevenage. The new Eppendorf House is 9,500 square feet, more than doubling its previous capacity, and will include a demonstration area for both Eppendorf and New Brunswick brand products.

SDIX said this week that it has sold its food safety and GMO businesses to Romer Labs for $13.5 million. Newark, Del.-based SDIX said that it will now concentrate on its life science business and its Advanced GAT technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.